CPHRF Stock: Cipher Pharmaceuticals Inc. Stock Price, Analysis & Insights
Get live CPHRF stock price $11.85, comprehensive Cipher Pharmaceuticals Inc. stock analysis, charts, news, and expert forecast. Real-time CPHRF stock data and investment insights.
Loading chart data...
Cipher Pharmaceuticals Inc. (CPHRF) Overview
Cipher Pharmaceuticals Inc. (CPHRF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, CPHRF trades at $11.85 with a market capitalization of 299.58M . Over the past 52 weeks, CPHRF has traded between $8.64 and $15.00 , with the current price positioned at approximately 50% of this...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 299.58M
- Current price: $11.85
- 52-week range: $8.64 - $15.00
- P/E ratio: 9.96
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Cipher Pharmaceuticals Inc. functions as a specialized pharmaceutical company based in Canada. The firm markets a diverse portfolio of therapies, including Epuris (CIP-ISOTRETINOIN), an isotretinoin formulation specifically developed for addressing s...
Company Information
- CEO
- Craig J. Mull
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 6
Contact Information
- Website
- https://www.cipherpharma.com
- Address
- 209 Oak Park Boulevard
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 10.0)
✓ Lower volatility stock (Beta: 0.48) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Cipher Pharmaceuticals Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Cipher Pharmaceuticals Inc.
- ⚠Investors should consider how Cipher Pharmaceuticals Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
299.58M
P/E Ratio (TTM)
9.96
Beta
0.48
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CPHRF with peer companies:
- Price
- $0.01
- Market cap
- 7.44M
- Price
- $10.00
- Market cap
- 292.48M
- Price
- $0.37
- Market cap
- 225.11M
- Price
- $0.00
- Market cap
- 884
- Price
- $2.90
- Market cap
- 245.80M
- Price
- $1.65
- Market cap
- 134.06M
- Price
- $0.20
- Market cap
- 211.81M
- Price
- $0.00
- Market cap
- 38.83K
- Price
- $0.85
- Market cap
- 122.57M
- Price
- $5.53
- Market cap
- 265.36M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.